There is no single diabetes drug that works for everyone. Many people with type 2 diabetes are resistant to the action of insulin, or their bodies cannot produce enough of it. As a result, they need medications to help control their blood sugar levels. To manage their diabetes, most patients are advised to follow a healthy diet and exercise routine, as well as take oral medication to manage their blood sugar level. However, there may soon be another option for patients who do not respond well to current treatments: a prescription injection called Rybelsus.
Even though it is still in clinical trials, interest in Rybelsus is growing among diabetes sufferers and physicians alike because of its potential benefits. In this article we’ll take an in-depth look at what you need to know about Rybelsus if you have type 2 diabetes…
What is Rybelsus?
Rybelsus is an investigational drug that has been designed to improve upon the current treatments available to patients with type 2 diabetes. Although there are many drugs used to treat diabetes, most of them act to reduce the amount of glucose that penetrates the blood stream by regulating the amount of insulin produced by the body.
Rybelsus, on the other hand, is designed to improve the cells’ response to insulin, meaning that you would need less insulin to achieve the same effect. This would result in lower blood sugar levels and fewer side effects.
How does Rybelsus Work?
Rybelsus has been designed as a fast-acting insulin. Insulin is a hormone that is produced by the pancreas and responsible for removing glucose from the bloodstream. Diabetes occurs when the pancreas does not produce enough insulin or when the cells do not respond to it.
Rybelsus works by binding to insulin receptors, which are proteins that are embedded in the membranes of cells in the body. These bind insulin in order to facilitate glucose absorption.
If there is not enough insulin to bind to these receptors, glucose cannot pass through the cell membrane and remains in the bloodstream. Rybelsus acts much faster than regular insulin and is designed to bind to the insulin receptors much more efficiently. This would result in glucose being removed from the bloodstream much more quickly and efficiently.
Pros & Cons of Rybelsus
Pros of Rybelsus
Fewer Side Effects: Because it works more efficiently than regular insulin, Rybelsus may result in lower blood sugar levels and fewer or no side effects.
Can be Used to Treat Type 1 Diabetes: Because it acts very quickly, Rybelsus can be used to treat type 1 diabetes, which is a condition where the body does not produce insulin at all.
Fewer Injections Required: Another benefit of Rybelsus is that it is injected only once a day, as opposed to multiple times a day.
No Need to Change Diet or Exercise Routine: As it does not work by reducing the amount of insulin in the body, Rybelsus does not require patients to change their diet or exercise routine. In fact, patients can consume whatever they usually eat.
No Risk of Over-Dosing: Another advantage of Rybelsus is that it cannot be overdosed, as it will not result in lowering the blood sugar levels too much.
Cons of Rybelsus
No Long-Term Data: Rybelsus has not been used by patients for a long period of time, so it is unclear how safe and effective it would be in the long term.
More Research is Needed: Although it shows promise, Rybelsus has not been approved or cleared by the Food and Drug Administration (FDA) so its safety and efficacy are yet to be determined.
Higher Cost: The only advantage of Rybelsus over other diabetes drugs is that it is injected only once a day. However, this does not justify the higher cost of this drug, which may make it unaffordable for some people who do not have insurance coverage.
The Big Issue with Rybelsus
The biggest issue with Rybelsus is that it is an insulin. Insulin, when it is injected, goes into the bloodstream and can lower blood sugar, which is not ideal for people with diabetes. The optimal glucose level for people with diabetes is between 80 and 120 mg/dl, but with insulin it can go too low, causing hypoglycemia, which can be fatal.
Rybelsus has the potential to revolutionize the way people with type 2 diabetes manage their disease. However, until it is approved and available to the public, it is too early to tell if it will live up to the hype. It is important to note that there are many drugs that have shown promise in earlier stages of development only to be a massive disappointment once approved and used by the general public. We hope that the positive preliminary results of Rybelsus will translate into a successful and beneficial treatment for people with diabetes.